Regulatory T Cells Tested in COVID-19 ARDS

Two men with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) survived after treatment with off-the-shelf regulatory T cells, also known as Tregs, Johns Hopkins physicians recently reported. The investigational allogenic Tregs with lung-homing markers were derived from cord blood.
Source: JAMA - Category: General Medicine Source Type: research